Replies to post #89376 on Avid Bioservices Inc (CDMO)

[freethemice]

Yes, it could be true for virus-infected cells. There does seem to be something different in that trial.

[sunstar]

I'm in full agreement on immuo-therapeutic bavi and HCV.

Treatments with bavi in cancer run for about 24 weeks or more, along with a chemo, then it’s bavi alone until disease progression. There may be an immunity established in some patients at some point. I think Peregrine is watching for that.

On the same subject, the bavi + ribavirin vs PEG Interferon + ribavirin HCV trial was for only 12 weeks. Word was, bavi was on the build. What would be the data for bavi if allowed to run for 18, 24 or more weeks. Some immunities to HCV?

Peregrine has those data and they just might further influence some big pharmas who are at the negotiation table. Possibly Roche??

Roche’s interferon, Pegasys, has awful side-effects, goes off patent in 2017, and earned Roche $1.8 billion in 2010.

Rehash.

sunstar